You have 9 free searches left this month | for more free features.

Besponsa

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

BESPONSA Injection 1 mg Special Investigation

Active, not recruiting
  • Acute Lymphocytic Leukemia
    • Tokyo, Japan
      Pfizer
    Jun 20, 2023

    Besponsa Post Marketing Surveillance Study

    Active, not recruiting
    • Hematologic Maligmancy
    • Inotuzumab ozogamicin
    • Seoul, Korea, Republic of
      Pfizer
    Oct 10, 2022

    Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • inotuzumab ozogamicin
    • (no location specified)
    Jan 6, 2023

    Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

    Not yet recruiting
    • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
    • Inotuzumab Ozogamicin
    • (no location specified)
    Nov 3, 2022

    ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)

    Not yet recruiting
    • ACUTE LYMPHOBLASTIC LEUKEMIA
    • (no location specified)
    Feb 17, 2023

    Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

    Recruiting
    • Lymphoblastic Leukemia
    • +2 more
    • Inotuzumab ozogamicin
    • +7 more
    • Chicago, Illinois
      University of Chicago Medical Center
    May 16, 2022

    B-cell Acute Lymphoblastic Leukemia Trial in United States (Inotuzumab ozogamicin, Prednisone Pill, Daunorubicin)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • Inotuzumab ozogamicin
    • +6 more
    • Nashville, Tennessee
    • +3 more
    Aug 14, 2022

    B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL Trial in Boston (Venetoclax, Dexamethasone, Inotuzumab Ozogamicin)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Oct 19, 2021

    Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5

    Withdrawn
    • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
    • +7 more
    • Inotuzumab Ozogamicin
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 13, 2022

    B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 25, 2022

    CD22 Positive, Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Houston (Inotuzumab

    Terminated
    • CD22 Positive
    • +2 more
    • Inotuzumab Ozogamicin
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 17, 2021

    Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma, ACUTE LYMPHOBLASTIC LEUKEMIA Trial in Worldwide (inotuzumab

    Active, not recruiting
    • Leukemia
    • +2 more
    • inotuzumab ozogamicin-dose level 2
    • Inotuzumab ozogamicin-dose level 1
    • Los Angeles, California
    • +45 more
    Mar 9, 2022

    Acute Lymphoblastic Leukemia Trial (Tisagenlecleucel, Blinatumomab, Inotuzumab)

    Withdrawn
    • Acute Lymphoblastic Leukemia
    • Tisagenlecleucel
    • +2 more
    • (no location specified)
    Jul 7, 2020

    Leukemia, Acute Lymphoblastic Trial in Worldwide (Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab

    Recruiting
    • Leukemia, Acute Lymphoblastic
    • Omitted Doxorubicin
    • +5 more
    • Brussels, Belgium
    • +100 more
    Dec 12, 2022

    Acute Lymphoblastic Leukemia in Remission, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia

    Terminated
    • Acute Lymphoblastic Leukemia in Remission
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 18, 2021

    B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial in Houston (biological, drug, other)

    Recruiting
    • B Acute Lymphoblastic Leukemia
    • B Lymphoblastic Lymphoma
    • Blinatumomab
    • +12 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2021

    Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial in

    Recruiting
    • Recurrent B Acute Lymphoblastic Leukemia
    • +3 more
    • Biospecimen Collection
    • +11 more
    • Birmingham, Alabama
    • +152 more
    Jan 30, 2023